CATHERINE C. TURKEL Insider Trading
Get free email notifications about insider trading for CATHERINE C. TURKEL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CATHERINE C. TURKEL. CATHERINE C. TURKEL is a Chief Development Officer in Novus Therapeutics, Inc. ($TKAI) and a President in Novus Therapeutics, Inc. ($TKAI).
Address: C/O NOVUS THERAPEUTICS, INC. 19900 MACARTHUR BLVD., SUITE 550 IRVINE 92612 CA
Companies in which CATHERINE C. TURKEL is an Insider
Eledon Pharmaceuticals, Inc.
Trading Symbol: ELDNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CATHERINE C. TURKEL: President, Chief Development Officer
Holdings: 90,576 shares
Current Value: $82,424
Latest Transaction: Mar 20 2020
$ELDN Market Capitalization: $20.25M
$ELDN Previous Close: $0.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of CATHERINE C. TURKEL
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 20 2020 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Option Exercise | A | 0.26 | 100,000 | 26,000 | 100,000 | |
Sep 30 2019 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Option Exercise | A | 0.67 | 75,000 | 50,250 | 75,000 | |
Sep 30 2019 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Option Exercise | A | 0.67 | 75,000 | 50,250 | 75,000 | |
May 22 2019 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Sell | S | 1.91 | 1,914 | 3,658 | 88,662 | 90.6 K to 88.7 K (-2.11 %) |
May 22 2019 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Sell | S | 1.96 | 7,623 | 14,953 | 90,576 | 98.2 K to 90.6 K (-7.76 %) |
Mar 18 2019 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Option Exercise | A | 3.72 | 50,000 | 186,000 | 50,000 | |
Mar 18 2019 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Grant | A | 0.00 | 20,000 | 0 | 98,199 | 78.2 K to 98.2 K (+25.58 %) |